Retroviral protease inhibiting compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/33 (2006.01) A61K 38/04 (2006.01) C07C 53/134 (2006.01) C07C 215/18 (2006.01) C07C 215/20 (2006.01) C07C 215/28 (2006.01) C07C 233/40 (2006.01) C07C 237/10 (2006.01) C07C 237/22 (2006.01) C07C 271/20 (2006.01) C07C 271/22 (2006.01) C07C 271/34 (2006.01) C07C 275/24 (2006.01) C07D 213/26 (2006.01) C07D 213/30 (2006.01) C07D 213/34 (2006.01) C07D 213/40 (2006.01) C07D 213/54 (2006.01) C07D 213/56 (2006.01) C07D 213/61 (2006.01) C07D 213/75 (2006.01) C07D 233/54 (2006.01) C07D 233

Patent

CA 2055670

A retroviral protease inhibiting compound is diclosed. The compound is of the formula (see Formula I) wherein R1 is hydrogen and R2 and R3 are independently selected from C6-aryl-C1-to-C6-alkyl, C9-to-C10-aryl-C1-to-C6-alkyl, C3-to-C7- cycloalkyl-C1-to-C6-alkyl and (heterocyclic)-C1-to-C6-alkyl; and A and B are independently selected from R6-C(O)-(NH)-(CH(R5))- C(O)- and R6-C(O)- wherein at each occurrence R6 is independently selected from R7-N(C1-to-C6-loweralkyl)-, R7-O- and R7-S- wherein R7 is heterocyclic or (heterocyclic)-C1-to-C6-alkyl and at each occurrence R5 is independently selected from C1-to-C6-loweralkyl; or a pharmaceutically acceptable salt, thereof. Also disclosed are a composition use and kit for inhibiting a retroviral protease and for treating an HIV infection. Also disclosed are processes and intermediates useful for the preparation of the retroviral protease inhibitors.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Retroviral protease inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral protease inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibiting compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2069702

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.